GENERINI, SERGIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.241
EU - Europa 2.756
AS - Asia 1.648
SA - Sud America 214
AF - Africa 48
OC - Oceania 39
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.947
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.193
RU - Federazione Russa 986
SG - Singapore 541
PL - Polonia 425
IT - Italia 413
CN - Cina 346
HK - Hong Kong 258
IE - Irlanda 230
SE - Svezia 217
VN - Vietnam 180
BR - Brasile 174
KR - Corea 127
DE - Germania 121
UA - Ucraina 84
FI - Finlandia 83
FR - Francia 75
GB - Regno Unito 59
TR - Turchia 41
IN - India 40
AU - Australia 38
CA - Canada 28
JO - Giordania 22
BD - Bangladesh 20
CH - Svizzera 19
AR - Argentina 15
JP - Giappone 13
IQ - Iraq 12
AT - Austria 11
ID - Indonesia 11
ZA - Sudafrica 9
MX - Messico 8
CI - Costa d'Avorio 7
EC - Ecuador 7
BJ - Benin 6
VE - Venezuela 6
ES - Italia 5
KE - Kenya 5
NL - Olanda 5
AL - Albania 4
MA - Marocco 4
NG - Nigeria 4
PH - Filippine 4
PK - Pakistan 4
SA - Arabia Saudita 4
TN - Tunisia 4
BG - Bulgaria 3
CL - Cile 3
CO - Colombia 3
HN - Honduras 3
JM - Giamaica 3
PE - Perù 3
PY - Paraguay 3
RO - Romania 3
SC - Seychelles 3
AE - Emirati Arabi Uniti 2
BB - Barbados 2
BH - Bahrain 2
ET - Etiopia 2
HU - Ungheria 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LB - Libano 2
LT - Lituania 2
LU - Lussemburgo 2
NP - Nepal 2
OM - Oman 2
UZ - Uzbekistan 2
BE - Belgio 1
BW - Botswana 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
GI - Gibilterra 1
GR - Grecia 1
IL - Israele 1
IR - Iran 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MD - Moldavia 1
MM - Myanmar 1
MQ - Martinica 1
MY - Malesia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PA - Panama 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
TH - Thailandia 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 8.947
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.005
Ashburn 449
Warsaw 423
Singapore 374
Fairfield 344
Chandler 295
Dublin 230
Hong Kong 204
Woodbridge 144
Jacksonville 130
Cambridge 129
Seattle 126
Seoul 124
Wilmington 120
San Jose 119
Beijing 109
Buffalo 109
Houston 88
Los Angeles 69
Milan 65
Ho Chi Minh City 64
Princeton 61
The Dalles 60
Lauterbourg 50
Medford 48
Boardman 44
Munich 44
Ann Arbor 41
Altamura 40
Izmir 37
Melbourne 37
Boston 35
Lawrence 35
Hefei 33
Moscow 32
Hanoi 31
New York 29
Rome 29
Florence 27
Shanghai 25
Dallas 20
Mumbai 20
Paris 20
Bern 18
San Diego 17
Turku 15
São Paulo 14
Bologna 13
Helsinki 13
Kent 13
Tokyo 12
Vienna 11
Yubileyny 11
Frankfurt am Main 10
Council Bluffs 9
Toronto 9
Da Nang 8
Dong Ket 8
Orem 8
Turin 8
West Jordan 8
Abidjan 7
Montreal 7
Naples 7
Poplar 7
Biên Hòa 6
Brooklyn 6
Cotonou 6
Norwalk 6
Salerno 6
Amman 5
Baghdad 5
Brescia 5
Chicago 5
Genoa 5
Guangzhou 5
Hillsboro 5
Jakarta 5
Johannesburg 5
Manchester 5
Mexico City 5
Miano 5
Nairobi 5
Phoenix 5
Salvador 5
Verona 5
Abuja 4
Andover 4
Bari 4
Brasília 4
Charlotte 4
Clifton 4
Curitiba 4
Greenwich 4
Guarulhos 4
Guayaquil 4
London 4
Ninh Bình 4
Philadelphia 4
Rio de Janeiro 4
Totale 5.917
Salva come PNG Salva come JPEG
Nome #
Effect of N-acetyl-L-cysteine on peroxynitrite and superoxide anion production of lung alveolar macrophages in systemic sclerosis 337
The fibrinolytic system components are increased in systemic sclerosis and modulated by Alprostadil (alpha1 ciclodestryn). 329
[Peripheral nervous system in limited systemic sclerosis]. 329
Health-related quality of life in systemic sclerosis as measured by the Short Form 36: relationship with clinical and biologic markers 207
DRESS syndrome in a patient with chronic hepatic encephalopathy. 207
Activin, a grape seed derived proanthocyanidin extract, reduces plasma levels of oxidative stress and adhesion molecules (ICAM-1, VCAM-1 and E-selectin) in systemic sclerosis. 203
Estrogens and neuropeptides in Raynaud's phenomenon. 191
Exercise Doppler echocardiography identifies preclinic asymptomatic pulmonary hypertension in systemic sclerosis. 190
Damage of cutaneous peripheral nervous system evolves differently according to the disease phase and subset of systemic sclerosis 187
Intravenous immunoglobulin modulates cutaneous involvement and reduces skin fibrosis in systemic sclerosis: an open-label study. 184
Oxidative stress in Systemic Sclerosis. 182
Longitudinal ultrasound and clinical follow-up of Baker's cysts injection with steroids in knee osteoarthritis. 179
Screening of distress among hospitalized patients in a department of internal medicine. 178
Evidence for the prevention of enthesitis in HLA-B27/hβ(2)m transgenic rats treated with a monoclonal antibody against TNF-α. 177
Health-related quality of life in systemic sclerosis as measured by the Short Form 36: relationship with clinical and biologic markers. 176
Angiotensin-converting enzyme I/D polymorphism and macrovascular disease in systemic sclerosis 170
Bcl-2, p53 and c-myc expression in juvenile dermatomyositis. 168
Circulating levels of Nepsilon-(carboxymethyl)lysine are increased in systemic sclerosis. 168
Discrepant expression of neprilysin on fibroblasts in diffuse systemic sclerosis. 162
Current Treatment Options in Raynaud's Phenomenon. 161
Somatostatin-induced modulation of inflammation in experimental arthritis 158
Ankylosing spondylitis: how diagnostic and therapeutic delay have changed over the last six decades. 156
High prevalence of polymorphisms of angiotensin-converting enzyme (I/D) and endothelial nitric oxide synthase (Glu298Asp) in patients with systemic sclerosis. 153
Evidence for the prevention of enthesitis in HLA-B27/hβ(2) m transgenic rats treated with a monoclonal antibody against TNF-α 151
Are Angiotensin Converting Enzyme and von Willebrand factor circulating levels useful surrogate parameters to monitor disease activity in Kawasaki disease? 150
Anti-endothelial cell antibodies in systemic sclerosis: significant association with vascular involvement and alveolo-capillary impairment. 149
Diene-conjugates and antibodies against oxidized low-density lipoproteins in systemic sclerosis. 149
Topical application of nerve growth factor in human diabetic foot ulcers. A study of three cases. 148
Urokinase-type plasminogen activator is the main plasminogen activator produced by synoviocytes of osteoarthritis and rheumatoid arthitis 148
Melatonin is a safe and effective treatment for chronic pulmonary and extrapulmonary sarciodosis 148
Cyclophosphamide pulse regimen in the treatment of alveolitis in systemic sclerosis. 147
Increased circulating levels of tissue kallikrein in systemic sclerosis correlate with microvascular involvement 147
A Sonographic (Us) Evaluation Of Ligaments Of Sacroiliac Joint In Healthy Subjects 147
NEPRILYSIN LEVELS IN PLASMA AND SYNOVIAL FLUID OF JUVENILE IDIOPATHIC ARTHRITIS PATIENTS. RHEUMATOL INT. 2005 JUN;25(5):336-40. EPUB 2004 MAR 3. 144
NGF, a useful tool in the treatment of chronic vasculitic ulcers in rheumatoid arthritis. 140
Evidence of immune activation against oxidized lipoproteins in inactive phases of juvenile chronic arthritis. 139
Nerve growth factor and neuropeptides circulating levels in systemic sclerosis (scleroderma). 134
The loss of endothelium dependent vascular tone control in systemic sclerosis. 132
Synoviocytes from osteoarthritis and rheumatoid arthritis produce plasminogen activators and plasminogen activator inhibitor-1 and display u-PA receptors on their surface. 131
Postural and kinesiologic evaluation in patients with early ankylosing spondylitis. 131
Evidence for hyaluronan production in the air pouch model in rats. 130
Clinical and laboratory features and disease outcome of kawasaki disease: the analysis of our experience and literature review. 123
Increased circulating nerve growth factor is directly correlated with disease activity in juvenile chronic arthritis. 121
Statin-induced, immune-mediated injury with simultaneous targeting of skeletal muscle, skin and liver 119
Reduction of bcl-2 in T cells during immunosuppressive therapy in patients with severe juvenile onset systemic lupus erythematosus. 116
The pathogenesis of inflammatory muscle diseases: on the cutting edge among the environment, the genetic background, the immune response and the dysregulation of apoptosis. 113
Erratum: "The fibrinolytic system components are increased in systemic sclerosis and modulated by Alprostadil (alpha1 ciclodestryn) (Clinical and Experimental Rheumatol (2005) vol. 23 (5) (671-677)) 112
TNFalpha blockade prevents the development of inflammatory bowel disease in HLA-B27 transgenic rats 112
Neuropeptides and steroid hormones in arthritis. 110
Raynaud's phenomenon and vascular disease in systemic sclerosis. 109
Vasculitides secondary to systemic diseases. 107
Systemic sclerosis. A clinical overview. 104
Therapy of spondylarthropathy in inflammatory bowel disease. 102
Peripheral nervous system involvement in systemic sclerosis: the median nerve as target structure. 95
New approaches to Raynaud's phenomenon [corrected]. 87
Nerve growth factor circulating levels are increased in Kawasaki disease: correlation with disease activity and reduced angiotensin converting enzyme levels. 82
The nervous system in systemic sclerosis (scleroderma). Clinical features and pathogenetic mechanisms. 81
Iliopsoas bursitis in rheumatoid arthritis. 81
Raynaud's phenomenon and systemic sclerosis. 80
Totale 8.971
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.836
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.836
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022354 10 37 10 11 8 15 13 15 15 13 92 115
2022/20231.019 105 153 39 102 86 188 124 53 96 15 32 26
2023/2024387 14 39 63 18 34 67 15 85 2 16 25 9
2024/20252.641 80 263 189 427 866 340 30 99 137 54 99 57
2025/20262.536 343 349 184 139 274 101 364 121 152 143 69 297
2026/202712 12 0 0 0 0 0 0 0 0 0 0 0
Totale 8.971